Niagen Bioscience Inc (NAGE)

EBITDA Margin

3.93%

Quarterly · Period ending:

NAGE logo

NAGE EBITDA Margin

Latest reported3.93%
NAGE Quarterly EBITDA Margin (0.00% → 3.93%)
High-resolution chart · PNG

NAGE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
3.9282%
22.8728%
14.1612%
15.1798%
13.1504%
18.3688%
26.9253%
8.7725%
1.5612%
-0.4604%
2.2976%
-2.6212%
-8.5962%
-6.4816%
-14.6409%
-3.112%
-35.5965%
-41.6189%
-27.7493%
-48.6769%
-29.0355%
-47.3677%
-36.8145%
-26.9323%
-21.6786%
-38.4942%
-64.9629%
-53.8123%
-61.1476%
-79.6178%
-88.3313%
-103.0542%
-99.1029%
-125.1713%
-114.2721%
-49.0796%
-58.0607%
-48.0998%
-35.4766%
-20.9389%
5.3808%
7.4834%
-26.3782%
4.1715%
-1.6819%
-15.745%
-24.3005%
-14.0882%
-40.899%
-57.8885%
-27.0393%
-43.4865%
-35.1697%
-57.0613%
-45.5345%
-39.8159%
-146.0962%
-242.8438%
-132.0819%
-125.716%
-89.3918%
-41.257%
-38.8686%
-49.555%
-9.7023%
6.8045%
-0.8188%
-5.3425%
-13.9738%
-15.2929%
-44.7349%
-56.4441%
-52.2112%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.